Camu, F., Malan, T., Wender, R., Snabes, M., & Hubbard, R. (2003). The COX-2-specific inhibitor parecoxib sodium is opioid-sparing and improves pain relief as part of a multimodal treatment strategy. BioMed Central.
Chicago Style CitationCamu, F., TP Malan, RH Wender, MC Snabes, i RC Hubbard. The COX-2-specific Inhibitor Parecoxib Sodium Is Opioid-sparing and Improves Pain Relief As Part of a Multimodal Treatment Strategy. BioMed Central, 2003.
Cita MLACamu, F., et al. The COX-2-specific Inhibitor Parecoxib Sodium Is Opioid-sparing and Improves Pain Relief As Part of a Multimodal Treatment Strategy. BioMed Central, 2003.
Atenció: Aquestes cites poden no estar 100% correctes.